Artificial apolipoprotein corona enables nanoparticle brain targeting.

Area of Science:

• Neuroscience
• Nanotechnology
• Pharmacology

Background:

• The blood-brain barrier (BBB) restricts the entry of therapeutic compounds into the brain, hindering treatments for neurological diseases.
• Nanotechnology offers potential solutions to enhance drug pharmacokinetics and brain targeting.
• Specific targeting of the cerebrovascular endothelium is crucial for effective brain drug delivery.

Purpose of the Study:

• To investigate the efficacy of apolipoprotein E4-decorated nanoparticles for enhancing brain drug delivery.
• To assess the impact of protein corona formation on nanoparticle translocation across the BBB.
• To evaluate the potential of this nanotechnology for treating brain diseases.

Main Methods:

• Polysorbate 80-stabilized nanoparticles were decorated with apolipoprotein E4 to form a protein corona.
• Nanoparticle binding to the cerebrovascular endothelium and translocation into the brain parenchyma were analyzed.
• Brain nanoparticle accumulation was quantified and compared between decorated and undecorated nanoparticles.

Main Results:

• Apolipoprotein E4 decoration specifically targeted cerebrovascular endothelium.
• Nanoparticle translocation into the brain parenchyma was significantly increased.
• Brain nanoparticle accumulation was 3-fold higher for decorated nanoparticles (119.8 pmol) compared to undecorated ones (40.5 pmol).

Conclusions:

• Apolipoprotein E4-decorated nanoparticles show significant potential for improving brain drug delivery.
• This nanotechnology strategy enhances nanoparticle accumulation in the brain parenchyma.
• The findings suggest high clinical translational potential for nanotechnology-based treatments for neurological disorders.